Periodontal Hastalıkta Sitokinlerin Rolü

Armiltage GC. Development of a classification of system for periodontal diseasesand conditions. Ann Periodontal 1999;4(1):1-6.

Lai H, Lo M-T, Wang T-T, Chen TH-T, Wu GH-M. A community based epidemiological study of periodontal disease in Keelung, Taiwan: a model from Keelung community based intagrated screening programme. J Clin Periodontal 2007;34:851-859.

Fox CH New considerations in the prevalance of periodontal disease. Curr Opin Dent; 1992;2:5- 11.

Fox CH, Jette AM, McGuire SM, Feldman HA, Douglass CW. Periodontal disease among New England elders. J Periodontal 1994;65:676-684.

Kelly M, Steele J, Nuttall N et al. The condition of supporting structures. In: Walker A, Cooper I (eds) Adult dental health survey: oral health in the United Kingdom 1998. The Stationery Office, London, 2000 pp 123-146.

Yucel- Lindberg T, Bage T. Inflammatory mediators in the pathogenesis of periodontitis. Expert Rev Mol Med. 2013; Aug 5;15.

Offenbacher S. Periodontal diseases: pathogenesis. Ann Periodontol. 1996; 1: 821-878.

Loos BG. Systemic effects of periodontitis. Ann R Australas Coll Dent Surg. 2006;18:27-29.

Nishimura M, Obayashi H, Mizuta I. TNF, TNF receptor type1, and allograft inflamma- tory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes. Hum Immunol. 2003;64:302–309.

Tret‘iak EB, Syroedova ON, Neuhaus O, Andreeva AV, Antsiferov MB, et al. Cytokines and their role in pathogenesis of diabetic retinopathy. Vestn Oftalmol. 2010; 126(6):53-7.

Cao Z., Li C., Zhu G. (2006). MMP-1 promoter gene polymorphism and susceptibility to chro- nic periodontitis in a Chinese population, Tissue Antigens, 68: 38-43.

Creemers E.E., Cleutjens J.P., Smits J.F., Daemen M.J. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to preventheart failure, Circ Res. 2001;89: 201-210.

Kang B.Y., Choi Y.K., Choi W.H., Kim K.T., Choi S.S., Kim K., Ha N.J. Two polymorphisms of interleukin-4 gene in Korean adult periodontitis, Arch Pharm Res. 2003;26: 482-486.

Marsh PD, Bradshaw DJ. Dental plaque as a biofilm. J Ind Microbiol. 1995;15:169-175.

Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontol 2000.2005;38:135-187.

Flemmig TF. Periodontitis. Ann Periodontol. 1999;4:32-38.

Listgarten MA. Pathogenesis of periodontitis. J Clin Periodontol. 1986;13:418-430.

Kornman K.S. The Pathogenesis of periodontal diseases. An overview. Fundamentals of perio- dontics 2nd Edition 1996; Quintessence Publishing USA:3-7.

Miller, W.D. The human mouth as a focus of infection. Dental Cosmos 1891;33:689-713.

Black, G.V. A work on Operative Dentistry. Medico-Dental Publishing Co., 1908,Chicago, IL.

Williams, C. R. And Paquette, D.W. Understanding the Pathogenesis ofPeriodontitis: A Cen- tury of Discovery. Journal of the International Academy of Periodontology 2000; 2/3:59-63.

Rosebury, T., Clarke, A.R., Engel, S.G. and Tergis, F. Studies of fusospirochetalinfection I. Pat- hogenicity for guinea pigs of individual and combined culture of spirochetes and other anaero- bic bacteria derived from the human mouth. Journal of Infectious Disease 1950; 87:217-225.

MacDonald, J.B., Sutton, R.M., Knoll, M.L., Modlener, E.M. and Grainger, R.M. The pathogenic components of an experimental mixed infection. Journal of Infectious Diseases 1956;98:15-20.

Keyes, P.H. and Jordan, H.V. Periodontal lesions in the Syrian hamster III. Findings related to an infectious and transmissible component. Archives of Oral Biology 1964; 9:377-400.

Socransky, S.S. Relationship of bacteria to the etiology of periodontal disease. Journal of Dental Researc 1970; 49:203-222.

Newman, M.G., Williams, R.C., Crawford, A., Mangianello, A. And Socransky, S.S. Predo- minant cultivable microbiata of periodontitis and periodontosis III. Periodontosis. Journal of Dental Research 1973; 52:290.

Newman, M.G., Socransky, S.S., Savitt, E.D., Propas, D.A. and Crawford, A. Studies of the mic- robiology of periodontosis. Journal of Periodontology 1976;47:373-379.

Schenkein, H. The pathogenesis of periodontal disease. Journal of Periodontology 1999;72:457- 470.

Zambon, J.J. Periodontal disease: Microbial factors. Annals of Periodontology 1996;1:879-925.

Darveau, R.L., Tanner, A. and Page, R.C. The Microbial Challange in Periodontitis. Periodonto- logy 2000. 1997;14:12-32.

Weski, O. Chronic marginal inflamation of the alveolar process with special regard to alveolar pyorrhea. Vierteljahrsschrift für Zahnheilkunde 1921;37:3-10.

Ivanyi, L. And Lehner, T. Stimulation of lymphocyte transformation by bacterial antigens in patients with periodontal disease. Archives of Oral Biology 1970; 15:1089-1096.

Klein, D.C. and Raisz, L.G. Prostaglandins: stimulation of bone resorpsion in tissue culture. Endocrinology 1970; 86:1436-1440.

Goodson, J.M. Prostaglandins: potential mediators of periodontal disease. Journal of Dental Research 1972; 51:375.

Horton. J.E., Raitz, L.G., Simmons, H.A., Oppenheim, J.J. and Mergenhagen, S.E. Bone resor- bing activity in supernatant fluid from cultured human peripheral blood leukocytes. Science 1972; 177:793-795.

Lavine, W., Stolman,J., Maderazo, E., Ward, P. and Cohen, R. Defective neutrophil chemotaxis in patients with early onset periodontitis. Journal of Dental Research 1976;55:212.

Page, R.C. and Schroeder, H.E. Pathogenesis of inflamatory periodontal disease. A summary of current work. Laboratory investigation 1976;33:235-249.

Page, R.C., Offenbacher, S., Schroder, H.E., et all. Advances in the pathogenesis of periodonti- tis: summary of developments, clinical implications and future directions. Periodontology 2000 1997;14:216-248.

Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med. 1998;9:248-266.

Önder F., Keskin E., İnterlökinlerin biyolojik etkileri. Yüzüncü Yıl Üniversitesi, Sağlık Bilimleri Dergisi. 2006;9(1): 127-138.

Fernandez-Real JM, Gutierrez C, Ricant W, Casamitjana R. The TNF-beta gene Nco I poly- morphism is not associated with hypertriglyceridemia or insulin resistance in lean and obese subjects. Biochem Biophys Res Commun 1997; 236:829–832.

Mak TW, Saunders M. The immune response: Basic and Clinical Principles. St. Louis Academic Press, 2005.

Fridman WH, Michon J. Pathophysiology of cytokines. Leuk Res. 1990;14:675- 677.

Oppenheim JJ, Neta R. Pathophysiological roles of cytokines in development, immunity, and inflammation. FASEB J. 1994;8:158-162.

Güner Ġ, Özmen D, Bayındır O. Sitokinler, Türkiye Klinikleri Journal of Medical Sciences. 1997;17, 65-74.

Goldsby RA, Kindt TJ, Osborne BA. Immunology, Fourth Edition, WH Freeman and Company, New York, 2000;303-327.

Tokgöz G. Sitokinler, Klinik İmmünoloji, Antıp A.S. Yayınları, Ankara, 1997;85-100

Türken M. Tip 1 ve Tip 2 Diabetes Mellitus Hastalıklarının Patogenezinde D Vitamini Eksikli- ğinin Rolünün Araştırılması.2011

Oppenheim JJ RF, Faltneyk CR. . Interleukins & Interferons. In Stites DP, Stobo JD, Wells JV, editors. Basic&Clinical Immunology. Sixth Edition. Beirut. 1987: 82-7.

Lowe GD. The relationship between infection, inflammation, and cardiovascular disease: an overview. Ann Periodontol. 2001;6:1-8.

Gemmell E, Marshall RI, Seymour GJ. Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontol 2000. 1997;14:112-143.

Tatakis DN. Interleukin-1 and bone metabolism: a review. J Periodontol. 1993;64:416-431.

Loe H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care. 1993; 16: 329-334.

Czuszak CA, Sutherland DE, Billman MA, Stein SH. Prostaglandin E2 potentiates interleu- kin-1 beta induced interleukin-6 production by human gingival fibroblasts. J Clin Periodontol. 1996;23:635-640.

Baykal Y, Karaayvaz M, Kutlu M. İnterlökinler, Türkiye Klinikleri Journal of Medical Sciences. 1998;18, 77-84.

Bochner BS, Luscinskas FW, Gimbrone MA, Jr., et al. Adhesion of human basophils, eosinop- hils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med. 1991;173:1553-1557.

Van der Zee E, Everts V, Beertsen W. Cytokines modulate routes of collagen breakdown. Re- view with special emphasis on mechanisms of collagen degradation in the periodontium and the burst hypothesis of periodontal disease progression. J Clin Periodontol. 1997;24:297-305.

Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to perio- dontal tissue destruction. J Periodontol. 2003;74:391-401.

Figueredo CM, Ribeiro MS, Fischer RG, Gustafsson A. Increased interleukin-1beta concentra- tion in gingival crevicular fluid as a characteristic of periodontitis. J Periodontol. 1999;70:1457- 1463.

Hou LT, Liu CM, Liu BY, et al. Interleukin-1beta, clinical parameters and matched cellular-his- topathologic changes of biopsied gingival tissue from periodontitis patients. J Periodontal Res. 2003;38:247-254.

Liu YC, Lerner UH, Teng YT. Cytokine responses against periodontal infection: protective and destructive roles. Periodontol 2000. 2010; 52: 163-206.

Preshaw PM, Taylor JJ. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? J Clin Periodontol. 2011; 38: 60-84.

Pfeilschifter J, Chenu C, Bird A, Mundy GR, Roodman GD. Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro. J Bone Miner Res. 1989; 4: 113-118.

Kirkwood KL, Cirelli JA, Rogers JE, Giannobile WV. Novel host response therapeutic approac- hes to treat periodontal diseases. Periodontol 2000. 2007; 43: 294-315.

Sakai A, Ohshima M, Sugano N, Otsuka K, Ito K. Profiling the cytokines in gingival crevicular fluid using a cytokine antibody array. J Periodontol. 2006;77: 856-864.

Reddy J, Chastagner P, Fiette L, Liu X, Thèze J. IL-2-induced tumor necrosis factor (TNF)-beta expression: Further analysis in the IL-2 knockout model, and comparison with TNF-alpha, lymphotoxin-beta, TNFR1 and TNFR2 modulation, International Immunology. 2001;3(2), 136- 147.

Panelli MC, Wang E, Phan G, Puhlmann M. Gene-expression profiling of the response of pe- ripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration, Genome Biology. 2001; 3(7), 25-35.

Encinas JA, Wicker LS, Peterson LB (1999). QTL influencing autoimmune diabetes and encep- halomyelitis map to a 0.15-cM region containing IL2, Nature Genetics., 21(2), 158-60.

Scarel-Caminaga RM, Trevilatto PC, Souza AP, Brito RB, Line SR. Investigation of an IL-2 polymorphism in patients with different levels of chronic periodontitis. J Clin Periodontol. 2002;29:587-591.

Ries WL, Seeds MC, Key LL. Interleukin-2 stimulates osteoclastic activity: increased acid pro- duction and radioactive calcium release. J Periodontal Res. 1989;24:242-246.

McFarlane CG, Meikle MC. Interleukin-2, interleukin-2 receptor and interleukin-4 levels are elevated in the sera of patients with periodontal disease. J Periodontal Res. 1991;26:402-408. 93. Kishimoto T., The biology of interleukin-6. Blood; 74:1-10, (1989).

Barath P. Fishbein M.C.,Cao J: Tumor necrosis factor gene expression in human vascular inti- mal smooth muscle cells detected by in situ hybridization. Am. J. Pathol.1990; 137:503-9.

Ogawa M (1993). Differentiation and proliferation of hematopoietic stem cells, Blood.,81, 2844- 2853.

Naka T, Nishimoto N, Kishimoto T. The paradigm of IL-6: From basic science to medicine, Arthritis Research.2002;4, 233-242.

Diab A, Zhu J. High IL-6 and low IL-10 in the central nervous system are associated with protracted relapsing EAE in DA rats, Journal of Neuropathology and Experimental Neurology. 1997;56(6), 641-50.

Kristiansen OP, Mandrup-Poulsen T. Interleukin-6 and diabetes: The good, the bad, or the indifferent, Diabetes. 2005;54, 114-24.

Bozkurt FY, Berker E, Akkus S, Bulut S. Relationship between interleukin-6 levels in gingival crevicular fluid and periodontal status in patients with rheumatoid arthritis and adult perio- dontitis. J Periodontol. 2000;71:1756-1760.

Page RC, Schroeder HE. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest. 1976;34:235-249.

Giannopoulou C, Kamma JJ, Mombelli A. Effect of inflammation, smoking and stress on gingi- val crevicular fluid cytokine level. J Clin Periodontol. 2003;30:145-153.

Yoshinari N, Kawase H, Mitani A, et al:Effects of scaling and root planning on the amounts of interleukin-1 receptor antagonist and the mRNA expression of interleukin-1beta in gingival crevicular fluid and gingival tissues. J Periodontal Res. 2004;39:158-167.

Marcaccini, A. M. Et al.. Circulating interleukin-6 and high-sensitivity C-reactive protein dec- rease after periodontal therapy in otherwise healthy subjects. Journal of Periodontolgy. 2009; 80, 594-602.

Fitzgerald JE, Kreutzer DL. Localization of interleukin-8 in human gingival tissues. Oral Mic- robiol Immunol. 1995;10:297-303.

Tsai CC, Ho YP, Chen CC. Levels of interleukin-1 beta and interleukin-8 in gingival crevicular fluids in adult periodontitis. J Periodontol. 1995;66:852-859.

Takahashi K, Azuma T, Motohira H, Kinane DF, Kitetsu S. The potential role of interleukin-17 in the immunopathology of periodontal disease. J Clin Periodontol. 2005;32:369-374.

Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A. IL-10 inhibits cytokine produ- ction by activated macrophages. J Immunol. 1991;147:3815-3822.

de Waal Malefyt R, Yssel H, Roncarolo MG, Spits H, de Vries JE. Interleukin-10. Curr Opin Immunol. 1992;4:314-320.

Al-Rasheed A, Scheerens H, Rennick DM, Fletcher HM, Tatakis DN. Accelerated alveolar bone loss in mice lacking interleukin-10. J Dent Res. 2003;82:632-635.

Al-Rasheed A, Scheerens H, Srivastava AK, Rennick DM, Tatakis DN. Accelerated alveolar bone loss in mice lacking interleukin-10: late onset. J Periodontal Res. 2004;39:194-198.

M. C. Horowitz and J. A. Lorenzo, B lymphocytes and the skeleton, Annals of the New York Academy of Sciences, 2007;vol. 11,17, pp. 82–93.

F. Elefteriou, Regulation of bone remodeling by the central and peripheral nervous system,

Archives of Biochemistry and Biophysics, 2008;vol. 473, no. 2, pp. ;231–236.

Schmitz J, Owyang A, Oldham E et al. IL- 33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2- associated cytokines. Immunity 2005;23:479–490.

Sağlam H. Diyabet ve enfeksiyonlar, Güncel Pediatri 2004;2:44-52.131.

S. Saidi, F. Bouri, P. Lencel et al., IL-33 is expressed in human osteoblasts, but has no direct effect on bone remodeling, Cytokine,2011; vol. 53, no. 3, pp. 347–354.

da Luz FA, Oliveira AP, Borges D, Brígido PC, Silva MJ. The physiopathological role of IL-33: new highlights in bone biology and a proposed role in periodontal disease. 2014;2014:342410.

Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 effector cytokines in inflammation. Immunity. 2008;28:454–467.

Queiroz-Junior CM, Silva MJ, Corrêa JD, Madeira MF, Garlet TP, Garlet GP, Cunha FQ, Te- ixeira MM, da Silva TA (2010) A controversial role for IL-12 in immune response and bone resorption at apical periodontal sites. Clin Dev Immunol 2010;327–417.

Schenkein HA, Koertge TE, Brooks CN, Sabatini R, Purkall DE, Tew JG. IL-17 in sera from patients with aggressive periodontitis. J Dent Res. 2010;89:943–947.

Marçal JR, Samuel RO, Fernandes D, de AraujoMS,NapimogaMH, Pereira SA, Clemente-Na- pimoga JT, Alves PM,Mattar R, Rodrigues V Jr, Rodrigues DB. Thelper cell type 17/regulatory T-cell immunoregulatory balance in human radicular cysts and periapical granulomas. J En- dod. 2010; 36:995–999.

Kramer JM, Gaffen SL. Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. J Periodontol. 2007;78:1083–1093.

Silva JA, Ferrucci DL, Peroni LA, Abrahão PG, Salamene AF, Rossa-Junior C, Carvalho HF, Stach-Machado DR. Sequential IL-23 and IL-17 and increased Mmp8 and Mmp14 expression characterize the progression of an experimental model of periodontal disease in type 1 diabe- tes. J Cell Physiol. 2012;227:2441–2450.

Bian Z, Guo Y, Ha B, Zen K, Liu Y. Regulation of the inflammatory response: enhancing neut- rophil infiltration under chronic inflammatory conditions. J Immunol. 2012;15:844–853.

D.M. Isaza-Guzma´n, N. Cardona-Ve´lez, D.E. Gaviria-Correa, M.C. Martı´nezPabo´ n, M.C. Castan˜ o-Granada, S.I. Tobo´n-Arroyave. Association study between salivary levels of interfe- ron (IFN)-gamma, interleukin (IL)-17, IL-21, and IL-22 with chronic periodontitis. Ar chiveso- foralbiology.2015;60;91–99.

Bradshaw, E. M., K. Raddassi, W. Elyaman, T. Orban, P. A. Gottlieb, S. C. Kent, and D. A. Hafler. Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytoki- nes inducing Th17 cells. J. Immunol. 2009;183: 4432–4439.

X. Xinyu, Z. Shuai, F.Yang ,Increased Th22 cells are independently associated ith Th17 cells in type 1 diabetes. Diabetes. 2014;46(1):90-8.

Li S,Joseph C, Becourt C, Klibi J, Luce S, Dubois- Laforque, Larger E, Boitard C, Benlagha K. Potential role of IL-17-producing iNKT cells in type 1 diabetes. Diabetes. 2014 30;9(4).

Simoni Y, Gautron AS, Beaudoin L, Bui LC, Michel ML, et al.. NOD mice contain an elevated frequency of Inkt17 cell that exacerbate diabetes. Eur J Immunol. 2011;41: 3574-3585.

Cytokines. Ġçinde Abbas, AK, Lichtman AH editör. Cellular and Molecular Immunology. Else- vier Saunders; 2005. pp. 243-274.

Dotta F, Fondelli C, Falorni A. Can NK cells be a therapeutic target in human type 1 diabetes? Eur J Immunol 2008;38(11):2961-3.

Lee, Y. K., R. Mukasa, R. D. Hatton, and C. T. Weaver. Developmental plasticity of Th17 and Treg cells. Curr. Opin. Immunol. 2009;21: 274–280.

Bickel M, Axtelius B, Solioz C, Attstro¨m R. Cytokine gene expression in chronic periodontitis. J Clin Periodontol 2001;28(9):840–7. 15.

Cardoso CR, Garlet GP, Crippa GE, Rosa AL, Ju´ nior WM, Rossi MA, et al. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Micro- biol Immunol 2009;24(1):1–6.

Dutzan N, Rivas C, Garcı´a-Sesnich J, Henrı´quez L, Rivera O, Dezerega A, et al. Levels of in- terleukin-21 in patients with untreated chronic periodontitis. J Periodontol 2011;82(10):1483– 9. 17.

Adibrad M, Deyhimi P, Ganjalikhani Hakemi M, Behfarnia P, Shahabuei M, Rafiee L. Signs of the presence of Th17 cells in chronic periodontal disease. J Periodontal Res 2012;47(4): 525–31. 18.

Dutzan N, Vernal R, Vaque JP, Garcı´a-Sesnich J, Hernandez M, Abusleme L, et al. Interleu- kin-21 expression and its association with proinflammatory cytokines in untreated chronic periodontitis patients. J Periodontol 2012;83(7): 948–54.

Kato-Kogoe N, Nishioka T, Kawabe M, Kataoka F, Yamanegi K, Yamada N, et al. The pro- motional effect of IL-22 on mineralization activity of periodontal ligament cells. Cytokine 2012;59(1):41–8. 20.

Navarrete M, Garcı´a J, Dutzan N, Henrı´quez L, Puente J, Carvajal P, Hernandez M, et al. Interferon-gamma, interleukins-6 and -4, and factor XIII-A as indirect markers of the clas- sical and alternative macrophage activation pathways in chronic periodontitis. J Periodontol 2014;85(5):751–60.

Papathanasiou E, Teles F, Griffin T, Arguello E, Finkelman M, Hanley J, et al. Gingival crevicu- lar fluid levels of interferon- gamma, but not interleukin-4 or -33 or thymic stromal lympho- poietin, are increased in inflamed sites in patients with periodontal disease. J Periodontal Res 2014;49(1):55–61. 22.

Napimoga MH, Nunes LH, Maciel AA, Demasi AP, Benatti BB, Santos VR, et al. Possible in- volvement of IL-21 and IL-10 on salivary IgA levels in chronic periodontitis subjects. Scand J Immunol 2011;74(6):596–602. 23.

Özçaka O, Nalbantsoy A, Buduneli N. Interleukin-17 and interleukin-18 levels in saliva and plasma of patients with chronic periodontitis. J Periodontal Res 2011;46(5):592–8.

Prakasam S, Srinivasan M. Evaluation of salivary biomarker profiles following non-surgical management of chronic periodontitis. Oral Dis 2014;20(2):171–7.

Camussi G., Albano E., Tetta C., Bussolino F.,The moleculer action of tumor necrosis factor- α.Eur. J. Biochem. 1991;202:3-14.

Buyan N., Bidcci A., Özkaya O., Ortac E., Bakkaloglu S., Gonca S., Peru H., Söylemezoglu O., Cinaz P., Leptin and resistin levels and their relationships with glucose metabolism in children with chronic renal insufficiency and undergoing dialysis. Nephrology. 2006;11:192-196.

Vendrell J, Broch M, Vilarrasa N, Molina A, Gomez JM, Gutierrez C, Simon I, Soler J, Richart C. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obe- sity. Obes Res. 2004;12(6):962-71.

Silha JV, Krsek M, Skrha J, Sucharda P, Nyomba BL, Murphy LJ. Plasma resistin, leptin and adi- ponectin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol. 2003 ;149(4):331-5.